当前位置: 首页 > 详情页

MiR-299-5p targets cell cycle to promote cell proliferation and progression of osteosarcoma

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Orthopedics, the Second Affiliated Hospital of Soochow University, Suzhou, China [2]Department of Orthopedics, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
出处:
ISSN:

关键词: Osteosarcoma MicroRNAs miR-299-5p Proliferation GEO

摘要:
OBJECTIVE: Osteosarcoma is a common primary bone tumor with high mortality. MicroRNA (miRNA, miR) is a small RNA with 20-25 nucleotides, which could regulate diverse biological processes by targeting 3'-UTR of gene to degrade it. MiR-299-5p has been reported to participate in the progression of many diseases, but the role in osteosarcoma is still uncertain. The aim of this work was to investigate the expression of miR-299-5p in osteosarcoma and its clinical significance. MATERIALS AND METHODS: The datasets of osteosarcoma miRNA was searched in Gene Expression Omnibus (GEO) datasets, including GSE65071, GSE39040, and GSE39055. Osteosarcoma U2 and MG-63 cells were cultured in our study. Cell proliferation level after transfection was detected by using Cell Counting Kit8 (CCK8) and colon formation assay. Cell cycles were explored using flow cytometer and cell protein expression levels after that the transfection was detected by Western blotting. RESULTS: We found that ROC curve analysis showed that miR-299-5p was a sensitivity diagnostic criteria and GSEA indicated that miRNA-299-5p may regulate cell cycle. Gain of function assay showed that miR-299-5p promotes cell cycle transition and proliferation. Reversely, the opposite results were observed with loss of function assay. At last, Western blotting assay showed that miR-299-5p may promote cell cycle transition by regulating CDK family. CONCLUSIONS: Our study demonstrated miR-299-5p can promote the progression of osteosarcoma by regulating the cell cycles.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 药学
JCR分区:
出版当年[2016]版:
Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Orthopedics, the Second Affiliated Hospital of Soochow University, Suzhou, China
通讯作者:
通讯机构: [1]Department of Orthopedics, the Second Affiliated Hospital of Soochow University, Suzhou, China [2]Department of Orthopedics, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院